Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized active safety monitoring for Zhengqing Fengtongning Injection based on real-world data
ChiCTR2100051214Phase 4Recruiting
- Sponsor
- Hunan Academy of Traditional Chinese Medicine
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zhengqing fengtongning, sponsored by Hunan Academy of Traditional Chinese Medicine. Primary endpoint: Safety index. Started Jan 2020; status: recruiting.
02
Drugs
zhengqing fengtongning
Beyond the preview
Go deeper on ChiCTR2100051214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051214.